Accéder au contenu
MilliporeSigma
Toutes les photos(1)

Principaux documents

C4835

Sigma-Aldrich

Carcinoembryonic Antigen human

≥95% (SDS-PAGE), buffered aqueous solution

Synonyme(s) :

Cancer-associated CEA

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Sélectionner une taille de conditionnement

25 μG
437,00 $

437,00 $


Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.


Sélectionner une taille de conditionnement

Changer de vue
25 μG
437,00 $

About This Item

Numéro MDL:
Code UNSPSC :
12352202
Nomenclature NACRES :
NA.32

437,00 $


Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.

Niveau de qualité

Essai

≥95% (SDS-PAGE)

Forme

buffered aqueous solution

Numéro d'accès UniProt

Conditions d'expédition

dry ice

Température de stockage

−20°C

Informations sur le gène

human ... CEACAM5(1048)

Description générale

Carcinoembryonic antigen(CEA) or CEA cell adhesion molecule 5 (CEACAM5), is encoded by the gene mapped to human chromosome 19q13.2.[1] CEACAM5 is a member of the CEACAM family. This glycosylated protein contains a typical N-terminal variable immunoglobulin (Ig)-like domain, constant Ig-like domain, and a hydrophobic transmembrane domain with a glycosylphosphatidylinositol lipid moiety.[2]

Application

Carcinoembryonic Antigen human has been used as a standard in electrochemical immunosensor[3] and developed surface plasmon resonance imaging (SPRi) immunosensor.[4] It has also been used as a tumor-associated antigen (TAA) in enzyme-linked immunosorbent assay[5]

Actions biochimiques/physiologiques

Carcinoembryonic antigen cell adhesion molecule 5 (CEACAM5) aids in cell adhesion and migration. In addition, this protein inhibits anoikis and thereby promoting tumorigenesis and metastasis. CEACAM5 is used as a biomarker to detect new cancer and cancer recurrence, particularly those with colorectal cancer. Upregulated expression of the gene enhances non-small-cell lung cancer (NSCLC) cell proliferation and invasion by regulating p38–Smad2/3 signaling. Therefore, CEACAM5 might be considered as an effective therapeutic target for treating NSCLC. Overexpression of the gene has also been observed in various types of cancer including gastrointestinal, pancreatic, and breast cancers.[2]

Conditionnement

Package size based on protein content

Qualité

Highly purified

Forme physique

Solution in 0.15 M phosphate buffered saline, pH 7.4, containing 0.1% sodium azide.

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 1

1 of 1

Xinwen Zhang et al.
The Journal of international medical research, 48(9), 300060520959478-300060520959478 (2020-10-01)
To detect the expression of CEA-related cell adhesion molecule 5 (CEACAM5) in non-small-cell lung cancer (NSCLC) and explore its function in the progression and development of NSCLC. qRT-PCR and immunohistochemistry were performed to detect CEACAM5 expression in human NSCLC tissues
Yingji Jin et al.
Oncotarget, 8(62), 105425-105439 (2017-12-30)
Serum autoantibodies against tumor-associated antigens (TAAs) have received much attention as potential biomarkers for early detection of cancers, since they can be detected in the early stages of cancers. Autoantibodies against Cancer Antigen 15-3 (CA15-3), carcinoembryonic antigen (CEA), Cancer Antigen
Beata Szymanska et al.
Analytical biochemistry, 609, 113964-113964 (2020-09-27)
Carcinoembryonic antigen (CEA) is one of the biomarkers most commonly used to determine tumor activity. In this work, a Surface Plasmon Resonance imaging (SPRi) immunosensor was developed. The immunosensor consists of a cysteamine linker attached to a gold chip and
Go, V.L.W.
Cancer, 38, 562-562 (1976)
Zeynep Altintas et al.
Talanta, 86, 377-383 (2011-11-09)
An immunoassay in optimised conditions with a highly sensitive surface plasmon resonance (SPR) based biosensor was developed for the detection of the cancer biomarker carcinoembryonic antigen (CEA). Different formats of the immunoassay were initially investigated on the surface of the

Questions

Reviews

No rating value

Active Filters

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique